Lymphoma Update: CAR T Therapies and Checkpoint Inhibitors

Share
Print
VIDEO05:17

Lymphoma experts Anas Younes, MD and Andrew Zelenetz, MD, PhD discuss the fast evolving research on CAR T cells and checkpoint inhibitors that is yielding the novel treatment options improving both outcomes and quality of life for people with lymphoma.